347 related articles for article (PubMed ID: 30194153)
21. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
Saeki Y; Mima T; Ishii T; Ogata A; Kobayashi H; Ohshima S; Ishida T; Tabunoki Y; Kitayama H; Mizuki M; Katada Y; Asaoku H; Kitano M; Nishimoto N; Yoshizaki K; Maeda M; Kon S; Kinoshita N; Uede T; Kawase I
Br J Haematol; 2003 Oct; 123(2):263-70. PubMed ID: 14531907
[TBL] [Abstract][Full Text] [Related]
22. Physicians, paraproteins and progress: diagnosis and management of myeloma.
Pawlyn C; Jackson GH
Br J Hosp Med (Lond); 2019 Feb; 80(2):91-98. PubMed ID: 30746991
[TBL] [Abstract][Full Text] [Related]
23. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
24. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion.
Kim HR; Kim BR; Park RK; Yoon KH; Jeong ET; Hwang KE
Tohoku J Exp Med; 2017 Jun; 242(2):137-142. PubMed ID: 28626164
[TBL] [Abstract][Full Text] [Related]
26. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.
Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF;
Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858
[TBL] [Abstract][Full Text] [Related]
27. [Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma].
Yang S; Wang W; Jin H; Zhong Y; Xie X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):371-378. PubMed ID: 27868410
[TBL] [Abstract][Full Text] [Related]
28. The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets.
Steiner N; Müller U; Hajek R; Sevcikova S; Borjan B; Jöhrer K; Göbel G; Pircher A; Gunsilius E
PLoS One; 2018; 13(8):e0202045. PubMed ID: 30096165
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.
Maciocia N; Wechalekar A; Yong K
Hematol Oncol; 2017 Dec; 35(4):432-439. PubMed ID: 27804161
[TBL] [Abstract][Full Text] [Related]
30. Proteomic profiling in plasma cell disorders: a feasibility study.
Mailankody S; Devlin SM; Korde N; Lendvai N; Lesokhin A; Landau H; Hassoun H; Ballagi A; Ekman D; Chung DJ; Patel M; Koehne G; Giralt S; Landgren O
Leuk Lymphoma; 2017 Jul; 58(7):1757-1759. PubMed ID: 27908223
[No Abstract] [Full Text] [Related]
31. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
32. The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.
Scudla V; Pika T; Budikova M; Petrova J; Minarik J; Bacovsky J; Langova K; Zivna J;
Neoplasma; 2010; 57(2):102-10. PubMed ID: 20099972
[TBL] [Abstract][Full Text] [Related]
33. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.
Mailankody S; Mena E; Yuan CM; Balakumaran A; Kuehl WM; Landgren O
Leuk Lymphoma; 2010 Dec; 51(12):2159-70. PubMed ID: 20958231
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
35. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
[TBL] [Abstract][Full Text] [Related]
36. Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events.
Landgren O
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):662-672. PubMed ID: 34889381
[TBL] [Abstract][Full Text] [Related]
37. Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.
Crowley MP; Quinn S; Coleman E; Eustace JA; Gilligan OM; O'Shea SI
J Thromb Thrombolysis; 2015 Feb; 39(2):245-9. PubMed ID: 25271000
[TBL] [Abstract][Full Text] [Related]
38. Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined Significance.
Crowley MP; Kevane B; O'Shea SI; Quinn S; Egan K; Gilligan OM; Ní Áinle F
Clin Appl Thromb Hemost; 2016 Sep; 22(6):554-62. PubMed ID: 26759370
[TBL] [Abstract][Full Text] [Related]
39. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
